Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

242.08 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Forget COVID: Moderna Is Turning Into a Cancer Company -- and Wall Street Is Taking Notice ↗
This company made headlines with its coronavirus vaccine. 
Via The Motley Fool
News headline image
2 Large-Cap Stocks to Research Further and 1 That Underwhelm
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are... 
Via StockStory
S&P 500 Top Movers: EFX and HAS Lead Today's Gainers, GM and DVA Fall ↗
Via Chartmill
Topics Stocks
S&P 500 Top Movers: Oct. 19, 2026 US Session Gainers and Losers ↗
Via Chartmill
Topics Stocks
Most Active S&P 500 Stocks on Oct. 19 ↗
Via Chartmill
Topics Stocks
News headline image
Moderna, Progyny, Azenta, Oscar Health, and agilon health Shares Skyrocket, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after investors rotated into defensive assets and priced in rising expectations that midter... 
Via StockStory
Topics Bonds Government
News headline image
The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winning ↗
AI-driven "biointelligence" is reshaping healthcare investing, with Guardant Health, Illumina, Eli Lilly and Moderna emerging as key stocks as data-driven testing, sequencing and therapies compound. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
3 Healthcare Stocks That Concern Us
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme... 
Via StockStory
News headline image
Another BioNTech Cancer Vaccine Just Hit a Major Setback. Is BNTX Stock Still a Buy? ↗
It has been a volatile year for the biotech. 
Via The Motley Fool
News headline image
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors. ↗
It was a head-turning headline. Here's why the market was buzzing. 
Via The Motley Fool
Topics ETFs
News headline image
Sandisk Is Dominating the S&P 500 in 2026. Can It Repeat in 2027? ↗
Sandisk is changing its business model to reduce its cyclicality. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
The Nasdaq-100's 6 Best Stocks This Year, and Whether They Can Keep Going ↗
Momentum is only half the battle. Their underlying companies still need to justify the continued bullishness of their stocks. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Azenta, Myriad Genetics, Moderna, Repligen, and PacBio Shares Plummet, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after capital-intensive growth equities experienced sharp sell-offs as elevated bond yields r... 
Via StockStory
Topics Bonds Economy
S&P 500 Top Movers: Today's Gainers and Losers ↗
Via Chartmill
Topics Stocks
Most-Active S&P 500 Stocks in Oct. 16, 2026 US Session ↗
Via Chartmill
Topics Stocks
S&P 500 Top Movers Today: HONA Tops Gainers, TWLO Tops Decliners ↗
Via Chartmill
Topics Stocks
S&P 500 Gap Downs on October 16: MRNA, TWLO and COHR Lead Declines ↗
Via Chartmill
Topics Stocks
News headline image
Meet the New Nasdaq-100 Stock That’s Crushing Nvidia, Micron, and Sandisk. Is It Too Late to Buy? ↗
This stock has soared more than 600% this year. 
Via The Motley Fool
Topics Artificial Intelligence
Discover which S&P500 stocks are making waves on Thursday. ↗
Via Chartmill
Top S&P500 movers in Wednesday's session ↗
Via Chartmill
News headline image
Moderna vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? ↗
Vertex raised its full-year outlook in Q2 with a growing pipeline across multiple disease areas. Moderna’s mRNA flu vaccine just cleared a key FDA hurdle with an expanding oncology pipeline behind it. 
Via The Motley Fool
Tuesday's pre-market session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
Moderna Is Now Worth More Than 3X as Much as BioNTech. Which Biotech Stock Is the Smarter Pick? ↗
Is bigger always better? Not necessarily. 
Via The Motley Fool
News headline image
These 3 Stocks Are Crushing the "Magnificent Seven" This Year -- Are They Still Buys? ↗
Forget the "Magnificent Seven" in favor of the "Tremendous Three"? 
Via The Motley Fool
News headline image
Moderna Now Trades 61% Above Wall Street's Average Price Target. Should You Sell? ↗
After a few years of stagnation, this stock is soaring. 
Via The Motley Fool
News headline image
Why Moderna Stock Surged Today ↗
The biotech could play a significant role in a national effort to combat cancer. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
This Stock Is Up More than 560% This Year, but It Could Drop by 38%, According to Wall Street ↗
Have Moderna’s shares risen too much, too fast? 
Via The Motley Fool
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. ↗
Via Chartmill
Discover which S&P500 stocks are making waves on Friday. ↗
Via Chartmill
News headline image
Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026? ↗
Axsome is posting 65% revenue growth but burning cash, while Moderna's vaccine market is cooling yet its oncology pipeline carries transformative potential. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.